Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People With HIV Who Inject Drugs

NCT05819411 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05819411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05819411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People With HIV Who Inject Drugs
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2021
Completion date
July 31, 2025
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, substance use disorders